National Comprehensive Cancer Network



NCCN Oncology Research Program (ORP)
NCCN Volasertib Research Grant Opportunity – Submit by October 30, 2014
NCCN ORP Recent News
NCCN ORP Affiliate Research Consortium
NCCN ORP Scientific Publications
NCCN ORP for Industry
NCCN ORP Investigator Steering Committee
NCCN ORP Testimonials
NCCN Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
NCCN Informed Consent Language Database
NCCN Specialized Imaging Research Consortium™ (SIRC)
NCCN ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees

NCCN Research & Business Resources

Learn more about clinical trials at this NCCN Member Institution.

Profile

As the Midwest's first and Ohio's only fully dedicated cancer hospital and research institute, the Ohio State University Comprehensive Cancer Center -James Cancer Hospital and Solove Research Institute (OSUCCC-James) is one of the nation's premier cancer centers for the prevention, detection and treatment of cancer. The OSUCCC-James is one of only 40 centers in the United States designated by the National Cancer Institute a Comprehensive Cancer Center. In addition, the OSUCCC-James is a founding member of the National Comprehensive Cancer Network (NCCN), an alliance of 20 of the world's leading cancer centers that develops clinical practice guidelines to improve the quality and effectiveness of care provided to patients with cancer.

The cancer program at Ohio State encompasses 278 comprehensive cancer center members from 12 of the 18 colleges at The Ohio State University and includes physicians from 16 specialties. The OSUCCC-James' singular focus on cancer has led to multiple accomplishments that have changed the standards of care with respect to prevention, diagnosis and treatment, in a way that substantially improves outcomes for cancer patients.

Facility

Only freestanding cancer hospital in Ohio

172-bed hospital

24-bed blood and marrow transplantation unit

26 basic research laboratories

Specialized surgical suites

Perianesthesia unit for pre and post-operative care

21 private chemotherapy suites

Pharmacy dedicated to chemotherapy

Leading edge radiation oncology department

Chemotherapy suites at multiple locations, including the 2 James Clinic, the Clinical Treatment Unit on 2 James, JamesCare in Dublin, JamesCare at Kenny Road and JamesCare at University Hospital East

Accreditation

Foundation for the Accreditation of Cellular Therapy (FACT): The James' Blood and Marrow Transplant (BMT) program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT). FACT accredited the BMT program for allogeneic and autologous transplantation, including clinical, collection (apheresis and perioperative services for bone marrow harvest), and processing. FACT accreditation attests to the high quality of The James' BMT program.

JCAHO: The Joint Commission (JCAHO) is an independent, not-for-profit organization that evaluates the quality and safety of care provided by healthcare organizations across the United States.

The American College of Surgeons Commission on Cancer: The American College of Surgeons Commission on Cancer (CoC) accredits cancer programs based on a comprehensive evaluation of: institutional and programmatic resources; program management and administration; clinical management; inpatient and outpatient care; supportive care services; research; quality management and improvement; cancer-data management; public education, prevention and detection; and professional education and staff support.

Clinical Trials

The James is one of only five centers in the country approved by the National Cancer Institute to conduct both phase I and phase II clinical trials for new anti-cancer drugs. The resulting benefit to patients is that they have access to some of the most advanced cancer treatments and clinical trials offered anywhere in the world.